Heaviest Healthcare Share Holdings in BMO Financial Corp.’s 13F Filing

Wall St. Watchdog reveals information regarding BMO Financial Corp.’s top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 162 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $2.461 billion.

  • Johnson & Johnson (NYSE:JNJ): On 06/30/2011, BMO Financial Corp. reported holding 2,737,057 shares with a market value of $182,069,022. This comprised 0.34% of the total portfolio. On 09/30/2011, BMO Financial Corp. reported holding 3,588,315 shares with a market value of $228,539,777. This comprised 0.48% of the total portfolio. The net change in shares for this position over the two quarters is 851,258. About Company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
  • Pfizer Inc. (NYSE:PFE): On 06/30/2011, BMO Financial Corp. reported holding 6,960,815 shares with a market value of $143,392,792. This comprised 0.27% of the total portfolio. On 09/30/2011, BMO Financial Corp. reported holding 11,407,537 shares with a market value of $201,685,258. This comprised 0.42% of the total portfolio. The net change in shares for this position over the two quarters is 4,446,722. About Company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  • Abbott Laboratories (NYSE:ABT): On 06/30/2011, BMO Financial Corp. reported holding 3,450,266 shares with a market value of $181,552,993. This comprised 0.34% of the total portfolio. On 09/30/2011, BMO Financial Corp. reported holding 3,749,017 shares with a market value of $191,724,727. This comprised 0.4% of the total portfolio. The net change in shares for this position over the two quarters is 298,751. About Company: Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company’s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
  • Eli Lilly & Co. (NYSE:LLY): On 06/30/2011, BMO Financial Corp. reported holding 3,789,831 shares with a market value of $142,232,353. This comprised 0.26% of the total portfolio. On 09/30/2011, BMO Financial Corp. reported holding 4,974,172 shares with a market value of $183,895,145. This comprised 0.38% of the total portfolio. The net change in shares for this position over the two quarters is 1,184,341. About Company: Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. The Company’s products are sold in countries around the world. Eli Lilly’s products include neuroscience products, endocrine products, anti-infectives, cardiovascular agents, oncology products, and animal health products.
  • Valeant Pharmaceuticals International (NYSE:VRX): On 06/30/2011, BMO Financial Corp. reported holding 4,056,195 shares with a market value of $210,759,888. This comprised 0.39% of the total portfolio. On 09/30/2011, BMO Financial Corp. reported holding 4,112,728 shares with a market value of $152,664,459. This comprised 0.32% of the total portfolio. The net change in shares for this position over the two quarters is 56,533. About Company: Valeant Pharmaceuticals International, Inc. develops and distributes drugs. The Company develops drugs for unmet medical needs in central nervous system disorders; and distributes generic and branded generic drugs in Latin America and Eastern Europe.
  • Unitedhealth Group Inc. (NYSE:UNH): On 06/30/2011, BMO Financial Corp. reported holding 3,225,249 shares with a market value of $166,358,349. This comprised 0.31% of the total portfolio. On 09/30/2011, BMO Financial Corp. reported holding 3,290,130 shares with a market value of $151,740,792. This comprised 0.32% of the total portfolio. The net change in shares for this position over the two quarters is 64,881. About Company: UnitedHealth Group Incorporated owns and manages organized health systems in the United States and internationally. The Company provides employers products and resources to plan and administer employee benefit programs. UnitedHealth also serves the health needs of older Americans, provides specialized care services, and provides health care information and research to providers and payers.
  • Humana Inc. (NYSE:HUM): On 06/30/2011, BMO Financial Corp. reported holding 1,850,114 shares with a market value of $149,008,183. This comprised 0.28% of the total portfolio. On 09/30/2011, BMO Financial Corp. reported holding 1,637,937 shares with a market value of $119,127,164. This comprised 0.25% of the total portfolio. The net change in shares for this position over the two quarters is -212,177. About Company: Humana Inc. is a managed health care company with medical members located in the United States and Puerto Rico. The Company offers coordinated health care through health maintenance organizations, preferred provider organizations, point-of-service plans, and administrative services products. Humana offers its products to employer groups, government-sponsored plans, and individuals.
  • Amgen Inc. (NASDAQ:AMGN): On 06/30/2011, BMO Financial Corp. reported holding 2,145,553 shares with a market value of $125,193,014. This comprised 0.23% of the total portfolio. On 09/30/2011, BMO Financial Corp. reported holding 2,141,279 shares with a market value of $117,684,692. This comprised 0.24% of the total portfolio. The net change in shares for this position over the two quarters is -4,274. About Company: Amgen Inc. discovers, develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The Company focuses its research on secreted protein and small molecule therapeutics, with particular emphasis on neuroscience and cancer. Amgen concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation.
  • Astrazeneca Plc (NYSE:AZN): On 06/30/2011, BMO Financial Corp. reported holding 1,920,428 shares with a market value of $96,155,829. This comprised 0.18% of the total portfolio. On 09/30/2011, BMO Financial Corp. reported holding 1,979,814 shares with a market value of $87,824,550. This comprised 0.18% of the total portfolio. The net change in shares for this position over the two quarters is 59,386. About Company: AstraZeneca PLC is a holding company. Through its subsidiaries, the Group researches, manufactures and sells pharmaceutical and medical products. The Group focuses its operations on seven therapeutic areas: Gastrointestinal, Oncology, Cardiovascular, Respiratory, Central Nervous System, Pain Control, Anaesthesia and Infection.
  • Forest Laboratories Inc. (NYSE:FRX): On 06/30/2011, BMO Financial Corp. reported holding 2,784,235 shares with a market value of $109,531,805. This comprised 0.2% of the total portfolio. On 09/30/2011, BMO Financial Corp. reported holding 2,787,616 shares with a market value of $85,830,699. This comprised 0.18% of the total portfolio. The net change in shares for this position over the two quarters is 3,381. About Company: Forest Laboratories, Inc. develops, manufactures, and sells both branded and generic forms of ethical products which require a physician’s prescription. The Company also manufactures non-prescription pharmaceutical products sold over-the-counter, which are used for the treatment of a wide range of illnesses. Forest’s products are marketed in the United States and eastern Europe.

(Note: Data regarding BMO Financial Corp.’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>